Cargando…
Chronic Elevation of Systemic Glucagon-Like Peptide-1 Following Surgical Weight Loss: Association with Nausea and Vomiting and Effects on Adipokines
We determined whether persistent nausea and vomiting (N/V) symptoms following Roux-en-Y gastric bypass surgery is due to elevated systemic glucagon-like peptide-1 (GLP-1) and leptin in female non-diabetic subjects. Subjects with N/V post-Roux-en-Y gastric bypass (RYGB) surgery had significantly elev...
Autores principales: | Al-Rasheid, Noora, Gray, Rosaire, Sufi, Pratik, Marina-Gonzalez, Nephtali, Al-Sayrafi, Mohammed, Atherton, Elizabeth, Mohamed-Ali, Vidya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297286/ https://www.ncbi.nlm.nih.gov/pubmed/25411121 http://dx.doi.org/10.1007/s11695-014-1507-4 |
Ejemplares similares
-
Acupuncture for patients with glucagon-like peptide-1 receptor agonists-induced nausea and vomiting: A systematic review protocol
por: Ding, Ning, et al.
Publicado: (2020) -
Postoperative nausea and vomiting
por: Moon, Young Eun
Publicado: (2014) -
Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon‐like peptide‐1 receptor agonists
por: Shiomi, Megumi, et al.
Publicado: (2018) -
ST-Segment Elevation in a Patient With Nausea, Vomiting, and Intracerebral Hemorrhage
por: Banerjee, Ranjan, et al.
Publicado: (2021) -
Anticipatory nausea in cyclical vomiting
por: McRonald, Fiona E, et al.
Publicado: (2005)